Stock Markets Analysis & Opinion

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

JPMorgan (NYSE:JPM) is set to cut hundreds of jobs in its asset and wealth management division, with most of the employees in support roles across the unit, per Bloomberg. These global reductions...

Return on equity is an investor-favorite metric when it comes to cherry-picking quality stocks. But ROE doesn’t always tell the complete story and an investor might make a mistake by selecting...

Enbridge Inc. (NYSE:ENB) has finally received the green signal from the Minnesota Public Utilities Commission (“PUC”) for its proposed C$9-billion Line 3 crude oil pipeline replacement...

Continuing with its retrenchment efforts, Wells Fargo (NYSE:WFC) will now slash around 202 jobs in the bank’s consumer banking business payroll services, per a filing with the state. The...

Atyr Pharma (LIFE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting...

Iterum Therapeutics PLC (ITRM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings...

Carolina Financial (CARO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces...

Investors might want to bet on AcelRx Pharmaceuticals (ACRX), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces...

The little bursts higher now and then, especially overnight, are quite annoying, but the big picture is as plain as day. The market crowd is living in the past.

Before I went on my pre-opening walk with my two larger dogs, I took a couple of snapshots (I am typing this nearly an hour later, well after the opening bell). My observation was, and continues to...

One of the stocks that has made the most headlines recently has been Boeing (NYSE:BA). Up until a few months ago, the company was in the news for getting order after order (military and civilian) as...